» Articles » PMID: 10605718

Mechanisms of Signaling Through Urokinase Receptor and the Cellular Response

Overview
Journal Thromb Haemost
Publisher Thieme
Date 1999 Dec 22
PMID 10605718
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases.

Manfredi M, Van Hoovels L, Benucci M, De Luca R, Coccia C, Bernardini P J Pers Med. 2023; 13(4).

PMID: 37109074 PMC: 10140982. DOI: 10.3390/jpm13040688.


The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective.

Benucci M, Damiani A, Russo E, Guiducci S, Li Gobbi F, Fusi P J Pers Med. 2022; 12(12).

PMID: 36556207 PMC: 9788564. DOI: 10.3390/jpm12121984.


Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience.

Infantino M, Morena L, Di Pietro M, Romanin B, Cimolato B, Rocca B Clin Immunol. 2022; 242:109091.

PMID: 35944880 PMC: 9356594. DOI: 10.1016/j.clim.2022.109091.


Immunocytochemical and biochemical detection of the urokinase-type plasminogen activator receptor (uPAR) in the rat tooth germ and in lipid rafts of PMA-stimulated dental epithelial cells.

von Germar A, Barth K, Schwab W Histochem Cell Biol. 2013; 140(6):649-58.

PMID: 23748245 DOI: 10.1007/s00418-013-1109-6.


Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.

Alfano M, Mariani S, Elia C, Pardi R, Blasi F, Poli G Blood. 2008; 113(8):1699-709.

PMID: 18941116 PMC: 2647677. DOI: 10.1182/blood-2008-02-138412.